Background: High-intensity focused ultrasound (HIFU) is the last introduced thermal treatment of thyroid nodules. Here we evaluated the results at 24 months after HIFU. Methods: Since 2016, HIFU was considered as a therapeutic option at our institute in patients with benign thyroid nodules presenting local symptoms. We searched in our database all patients who had undergone thyroid HIFU and selected for the study only cases followed-up for at least 24 months after the treatment. Volume reduction rate (VRR) was evaluated. A reduction above 50% defined the success of HIFU. Results: Thirty-one nodules of 31 patients (24 females and 7 males, median age 67 years) with median major diameter from 17 to 34 mm and estimated nodule volume of 5.48 mL ...
BACKGROUND: High-intensity focussed ultrasound (HIFU) is a non-invasive ablative technique utilising...
We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5-10 mm, and whether...
Background: Surgery is the therapy of choice in primary hyperparathyroidism (PHPT), although other l...
Background Outcomes of high-intensity focused ultrasound (HIFU), as a non-surgical treatment option ...
Purpose: To evaluate first-year efficacy and changes in pressure symptoms and health-related quality...
Session: Other TumorsBackground: Benign thyroid nodules are prevalent among the general population a...
High-intensity focused ultrasound (HIFU) is a promising form of thermal ablation of benign thyroid n...
High-intensity focused ultrasound (HIFU) is a promising ablation technique for benign thyroid nodule...
Background: High-intensity focused ultrasound (HIFU) allows to inflict intracorporal thermal lesions...
Objective Since it is unclear whether clinical parameters can independently predict the subsequent t...
OBJECTIVE: To examine the association between the appearance of hyperechoic marks (HEMs) during hig...
Purpose: We compared the effectiveness of high intensity focused ultrasound (HIFU) and radioiodine (...
To evaluate the frequency and the magnitude of growth in benign nodules during 120 months of follow-...
Background: The aim of the present trial on ultrasound (US)-guided laser ablation therapy (LAT) of s...
Abstract Objective Microwave ablation (MWA) is a minimally invasive technique for the treatment of b...
BACKGROUND: High-intensity focussed ultrasound (HIFU) is a non-invasive ablative technique utilising...
We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5-10 mm, and whether...
Background: Surgery is the therapy of choice in primary hyperparathyroidism (PHPT), although other l...
Background Outcomes of high-intensity focused ultrasound (HIFU), as a non-surgical treatment option ...
Purpose: To evaluate first-year efficacy and changes in pressure symptoms and health-related quality...
Session: Other TumorsBackground: Benign thyroid nodules are prevalent among the general population a...
High-intensity focused ultrasound (HIFU) is a promising form of thermal ablation of benign thyroid n...
High-intensity focused ultrasound (HIFU) is a promising ablation technique for benign thyroid nodule...
Background: High-intensity focused ultrasound (HIFU) allows to inflict intracorporal thermal lesions...
Objective Since it is unclear whether clinical parameters can independently predict the subsequent t...
OBJECTIVE: To examine the association between the appearance of hyperechoic marks (HEMs) during hig...
Purpose: We compared the effectiveness of high intensity focused ultrasound (HIFU) and radioiodine (...
To evaluate the frequency and the magnitude of growth in benign nodules during 120 months of follow-...
Background: The aim of the present trial on ultrasound (US)-guided laser ablation therapy (LAT) of s...
Abstract Objective Microwave ablation (MWA) is a minimally invasive technique for the treatment of b...
BACKGROUND: High-intensity focussed ultrasound (HIFU) is a non-invasive ablative technique utilising...
We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5-10 mm, and whether...
Background: Surgery is the therapy of choice in primary hyperparathyroidism (PHPT), although other l...